Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Making Precision Medicine a Reality

Posted on April 24th, 2017 by in Chemistry

Precision medicine is no longer just a promising new development discussed only by medical professionals and industry insiders at conferences and in journals. In early 2015, former U.S. President Barack Obama announced the $215 million Precision Medicine Initiative Continue reading “Making Precision Medicine a Reality” »

Making Medicine More Precise

Posted on March 13th, 2017 by in Pharma R&D

Precision medicine, which takes the individual into account like never before, has been a thrilling development in the field of medicinal research. It is an area that has shown particular promise in the treatment of cancer, Continue reading “Making Medicine More Precise” »

Start-Up Spotlight: XEPTAGEN

Posted on March 10th, 2017 by in Pharma R&D

Half the battle of treating a disease is to first diagnose it in a timely manner. XEPTAGEN, based in Venice, Italy, aims to develop effective, inexpensive tests to diagnose cancer and liver disease. Continue reading “Start-Up Spotlight: XEPTAGEN” »

Emerging Oncology Drugs in Pharma R&D Pipeline

Posted on March 2nd, 2017 by in Pharma R&D

Cancer. It’s the 2nd leading cause of death in this country (1), and a disease feared by patients and healthcare professionals alike. Today’s cancer treatments vary in nature, and also, efficacy and levels of side effect profiles. Continue reading “Emerging Oncology Drugs in Pharma R&D Pipeline” »

  1. 1
  2. 2
  3. 3